Metronidazole 0.2% & Dextrose 5% InfusionThird Party Manufacturing in India
Looking to get Metronidazole 0.2% & Dextrose 5% Infusion manufactured under your brand? Our WHO-GMP certified partner facilities support PCD franchise partners and global export opportunities structured across 25+ countries.
Mechanism of Action
Metronidazole 0.2% & Dextrose 5% Infusion delivers metronidazole in a pre-mixed isotonic dextrose solution for convenient intravenous administration. The metronidazole component works by penetrating bacterial and protozoal cells where it undergoes intracellular reduction by bacterial nitroreductases. The reduced metabolites then bind to microbial DNA and inhibit nucleic acid synthesis, resulting in cell death.
The 5% dextrose component serves as a caloric source and maintains the osmotic balance of the solution, making it ready-to-use without additional reconstitution. This combination reduces the risk of medication errors and saves nursing time in hospital settings. Metronidazole is specifically active against obligate anaerobes including Bacteroides fragilis, Clostridium species, and Peptostreptococcus species.
This fixed-dose infusion format is widely preferred in hospital formularies because it simplifies inventory management and reduces preparation steps in the pharmacy.
Therapeutic Uses & Indications
Therapeutic Uses
Metronidazole 0.2% & Dextrose 5% Infusion is prescribed for:
- Intra-Abdominal Infections: Peritonitis, appendicitis complications, and liver abscess caused by anaerobic bacteria
- Gynecological Infections: Endometritis, pelvic inflammatory disease, and postoperative gynecological infections
- Surgical Prophylaxis: Preoperative bowel preparation before colorectal, gynecological, and abdominal surgeries
- Bacteremia: Anaerobic septicemia requiring immediate IV antibiotic coverage
Why Manufacturers Choose This Combination
The pre-mixed metronidazole-dextrose infusion is preferred by hospitals for its convenience and reduced risk of compounding errors. Indian manufacturers with WHO-GMP certification and IV fluid production lines can produce this product at competitive costs. It enjoys steady demand from district health programs, government hospitals, and private healthcare chains across India and export markets.
This makes Metronidazole 0.2% & Dextrose 5% Infusion a high-volume product for third party manufacturing and institutional supply.
Dosage Forms We Manufacture
Frequently Asked Questions
What is the minimum order quantity for Metronidazole 0.2% & Dextrose 5% Infusion?
What dosage forms of Metronidazole 0.2% & Dextrose 5% Infusion can you manufacture?
Are your manufacturing facilities WHO-GMP certified?
Can you manufacture Metronidazole 0.2% & Dextrose 5% Infusion for export?
What grade standards do you follow for Metronidazole 0.2% & Dextrose 5% Infusion?
Get Metronidazole 0.2% & Dextrose 5% Infusion made under your brand
- WHO-GMP certified facilities
- Quote within 24 hours
- MOQ from 10,000 units per batch
+91 9689237122 · replies within hours
Our Manufacturing Capabilities
- WHO-GMP Certified Partner Plants
- 25+ years of pharma industry experience
- PCD Franchise with monopoly rights
- Export support across 25+ countries
- Small batch to commercial scale
- Custom formulation development
Packaging Options
Non-PVC IV infusion bag 500ml. Overwrapped with protective pouch. Hanger bag with aluminum seal. Labels with barcode. Secondary packaging in export-grade corrugated boxes.
Start Manufacturing Metronidazole 0.2% & Dextrose 5% Infusion Today
Celesta Healthcare provides WHO-GMP certified third-party manufacturing for Metronidazole 0.2% & Dextrose 5% Infusion across all dosage forms. PCD franchise and export orders welcome.